← Contracts
PT
Ajuste direto para aquisição de IVACAFTOR [150 MG; CÁP/ COMP], IVACAFTOR + TEZACAFTOR + ELEXACAFTOR [75 + 50 + 100 MG; CÁP/ COMP], IVACAFTOR [75 MG; CÁP/COMP], IVACAFTOR [75 MG;GRAN], IVACAFTOR [50 MG;GRAN], IVACAFTOR + TEZACAFTOR + ELEXACAFTOR [37.5 MG + 25 MG + 50 MG; CÁP/COMP], LUMACAFTOR + IVACAFTOR [100 MG + 125 MG; GRAN; SAQUETA] e LUMACAFTOR + IVACAFTOR [150 MG + 188 MG; GRAN; SAQUETA]
ID 13200070
· Portal BASE
Price
Base Price
€6,855,594
.00
Effective Price
€1,022,680
.00
-85.1%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Porto, Porto
- Bidder Count
- —
Winner
VERTEX PHARMACEUTICALS (PORTUGAL), UNIPESSOAL LDA.
NIF 513481613
Dates
- Publication
- 07 Feb 2026
- Celebration
- 02 Feb 2026
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
- Authority
- 745
- Supplier
- 281
- Number of Awards
- 21
- Rule
- A1 repeat direct award: 21 awards within 36 months
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 6855594.0
- Total effective price
- 1022680.0
- Ratio
- 0.1492
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.1492 outside [0.5, 1.5]
Detected 2026-03-06